On March 5, 2025, The Hospital for Sick Children (SickKids) received a significant breakthrough in pediatric research with an $11.7 million award from Genome Canada. As part of the Canadian Precision Health Initiative, a total of $81 million in...
Hai-Ling Margaret Cheng is a principal investigator at our Translational Biology and Engineering Program, whose lab focuses on developing new magnetic resonance technologies for improved cardiac diagnostics. These insights and capabilities will enable the investigation of novel therapies to regenerate new, healthy heart tissue.
For more details on the true potential of advanced imaging as it relates to heart failure, see Prof. Cheng’s commentary from February 2017.